Pericle F - Search Results

1

Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells.

Bronte V, Wang M, Overwijk WW, Surman DR, Pericle F, Rosenberg SA, Restifo NP. Bronte V, et al. Among authors: pericle f. J Immunol. 1998 Nov 15;161(10):5313-20. J Immunol. 1998. PMID: 9820504 Free PMC article.

2

Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes.

Pericle F, Kirken RA, Bronte V, Sconocchia G, DaSilva L, Segal DM. Pericle F, et al. J Immunol. 1997 Sep 15;159(6):2580-5. J Immunol. 1997. PMID: 9300676

3

Therapeutic tumor immunity induced by polyimmunization with melanoma antigens gp100 and TRP-2.

Mendiratta SK, Thai G, Eslahi NK, Thull NM, Matar M, Bronte V, Pericle F. Mendiratta SK, et al. Among authors: pericle f. Cancer Res. 2001 Feb 1;61(3):859-63. Cancer Res. 2001. PMID: 11221870

4

HIV-1 infection induces a selective reduction in STAT5 protein expression.

Pericle F, Pinto LA, Hicks S, Kirken RA, Sconocchia G, Rusnak J, Dolan MJ, Shearer GM, Segal DM. Pericle F, et al. J Immunol. 1998 Jan 1;160(1):28-31. J Immunol. 1998. PMID: 9551952

5

CD44 is a cytotoxic triggering molecule on human polymorphonuclear cells.

Pericle F, Sconocchia G, Titus JA, Segal DM. Pericle F, et al. J Immunol. 1996 Nov 15;157(10):4657-63. J Immunol. 1996. PMID: 8906846

6

An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.

Pericle F, Giovarelli M, Colombo MP, Ferrari G, Musiani P, Modesti A, Cavallo F, Di Pierro F, Novelli F, Forni G. Pericle F, et al. J Immunol. 1994 Dec 15;153(12):5659-73. J Immunol. 1994. PMID: 7989764

7

CD38 triggers cytotoxic responses in activated human natural killer cells.

Sconocchia G, Titus JA, Mazzoni A, Visintin A, Pericle F, Hicks SW, Malavasi F, Segal DM. Sconocchia G, et al. Among authors: pericle f. Blood. 1999 Dec 1;94(11):3864-71. Blood. 1999. PMID: 10572102 Free article.

8

CD40-CD40L interactions provide "third-party" costimulation for T cell response against B7-1-transfected human breast tumor cells.

Pericle F, Epling-Burnette PK, Podack ER, Wei S, Djeu JY. Pericle F, et al. J Leukoc Biol. 1997 Feb;61(2):201-8. doi: 10.1002/jlb.61.2.201. J Leukoc Biol. 1997. PMID: 9021926

9

Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells.

Kirken RA, Erwin RA, Taub D, Murphy WJ, Behbod F, Wang L, Pericle F, Farrar WL. Kirken RA, et al. Among authors: pericle f. J Leukoc Biol. 1999 Jun;65(6):891-9. doi: 10.1002/jlb.65.6.891. J Leukoc Biol. 1999. PMID: 10380915

10

Antitumoral effect of a nonviral interleukin-2 gene therapy is enhanced by combination with 5-fluorouracil.

Bishop JS, Thull NM, Matar M, Quezada A, Munger WE, Batten TL, Muller S, Pericle F. Bishop JS, et al. Among authors: pericle f. Cancer Gene Ther. 2000 Aug;7(8):1165-71. doi: 10.1038/sj.cgt.7700216. Cancer Gene Ther. 2000. PMID: 10975677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters